Skip to main content
. 2018 Jul 2;16(3):3690–3698. doi: 10.3892/ol.2018.9055

Figure 5.

Figure 5.

TS significantly decreases the diameter of tumor-associated arteries and tumor microvascular vessels when compared with those in the TACE group (P<0.05). (A) Hepatic artery (d). (B) Proper hepatic artery (d). (C) Hepatic artery branches (d). (D) Splenic artery (d). (E) Gastroduodenal artery (d). (F) Left gastric artery (d). (G) Microvascular vessels (d). TACE, transarterial chemoembolization; TS group, TACE combined with sorafenib. *P<0.05; **P<0.01; ***P<0.001. (d) difference. TACE, transarterial chemoembolization.